RAPT Therapeutics Engages in Investor Conferences
RAPT Therapeutics, Inc. (NASDAQ: RAPT), known for its innovative work in the biopharmaceutical sector, is gearing up to take part in a series of notable investor conferences. These events will allow stakeholders to gain insights into the company’s progress and future plans.
Upcoming Conferences Participation
Members of the RAPT management team will be participating in two pivotal conferences this month:
Leerink Global Healthcare Conference
This conference features a fireside chat scheduled for Tuesday, March 11, offering a platform for RAPT to share updates and engage with investors.
Barclays Global Healthcare Conference
On Wednesday, March 12, RAPT will take part in another important discussion at the Barclays 27th Annual Global Healthcare Conference. This session will present an excellent opportunity for leaders from RAPT to connect with the investment community.
Accessing Live Discussions
For those interested in following these discussions, RAPT Therapeutics provides access to live webcasts along with recorded sessions available afterward. Interested parties can visit the RAPT Therapeutics website for details to ensure they do not miss any updates.
About RAPT Therapeutics
RAPT Therapeutics is a pioneering biopharmaceutical company dedicated to advancing meeting critical medical needs through innovative therapies. Focused on immunology, RAPT Therapeutics leverages its unique expertise to develop treatments that address inflammatory and immunological challenges. The company's commitment to improving patient outcomes is reflected in their forward-thinking approach to drug development, targeting the underlying immune responses that contribute to various diseases.
Investor and Media Contacts
For further information, RAPT has dedicated contacts for investor inquiries:
Sylvia Wheeler
Email: swheeler@wheelhouselsa.com
Additionally, for media relations, Aljanae Reynolds can be reached at:
Email: areynolds@wheelhouselsa.com
Frequently Asked Questions
What is RAPT Therapeutics known for?
RAPT Therapeutics is recognized for its focus on developing immunology-based therapies aimed at treating inflammatory and immunological conditions.
When are the upcoming investor conferences?
The RAPT management team will be participating in the Leerink Global Healthcare Conference on March 11 and the Barclays Global Healthcare Conference on March 12.
How can I access the live webcasts of the conferences?
Live webcasts and recordings of the conference discussions can be accessed on the RAPT Therapeutics website.
Who can I contact for investor inquiries at RAPT?
Sylvia Wheeler is the contact person for investor inquiries at RAPT Therapeutics.
What type of therapies does RAPT develop?
RAPT focuses on developing novel therapies tailored to enhance immune response for patients suffering from various inflammatory and immunological diseases.